AdaptHealth Corp. (AHCO), headquartered in Plymouth Meeting, Pennsylvania, is a leading provider of home healthcare equipment, medical supplies and related services in the United States. The company commenced operations in 2012 and went public on the NASDAQ in 2019. Today, it operates across all contiguous states in America, enriching lives of countless patients through a comprehensive range of services that facilitate quality healthcare right in the comfort of their homes.
AdaptHealth primarily provides home medical equipment (HME), supplies and services to individuals suffering from chronic diseases, the elderly, and patients who are recuperating after surgeries or hospital stays. The company's extensive HME inventory includes respiratory therapy equipment like oxygen concentrators, sleep apnea machines (CPAP and BIPAP), ventilators, as well as mobility enhancing equipment such as wheelchairs and walkers.
Beyond providing HME, the company also supplies a vast range of home healthcare products like wound care dressings, urological supplies, incontinence supplies, ostomy supplies, and diabetic care equipment. This variety of healthcare products allows the company to cater to a wide array of patient needs, making it a one-stop solution for home healthcare.
Remarkably, AdaptHealth's model involves more than just supplying equipment. Its teams work to understand patient needs, liaise with healthcare providers to ensure fitting equipment choices, and provide professional setup services in patients' residences. This patient-centric approach underlines AdaptHealth’s commitment to personalized, integrated care.
AdaptHealth's innovative take on healthcare distribution has unfolded to beneficial outcomes for both the company and its customers. It leverages sophisticated technology and proprietary software systems to streamline inventory management, prescription confirmations, insurance claim processing, and patient communication. By redefining the traditional patient-provider relationship and introducing innovative care delivery models, AdaptHealth is instrumental in revolutionizing home healthcare in the U.S.
However, like every business, AdaptHealth too faces challenges. Factors such as changes in Medicare/Medicaid reimbursement rates, competitive bidding, and regulatory changes can impact its business. Yet, irrespective of the challenges it faces, the company seems poised to continue expanding its reach and influence.
In conclusion, AdaptHealth Corp. stands out as a pioneering player in the American home healthcare market. The comprehensive suite of services offered and the efforts towards patient-oriented care, supported by technological innovation, make AdaptHealth a true leader in this domain.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
AdaptHealth Corp. (NASDAQ:AHCO) reported Q3 2026 results that exceeded market revenue expectations, with sales of $745.6 million, though revenue declined 9.1% year-on-year. The company's GAAP loss of $1.13 per share significantly missed analyst estimates, but adjusted EBITDA and full-year guidance were above consensus. Shares surged 9.6% following the mixed results, as the company focuses on Sleep Health, Respiratory Health, and Wellness-at-Home.
Argus has lowered its target price for AdaptHealth Corp. (AHCO) to $5.00, citing the company's engagement in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services. The current price of AHCO stock is $5.99.
Argus has updated its forecast for AdaptHealth Corp. (AHCO), raising its target price to $6.00. The company provides patient-centered, healthcare-at-home solutions, including home medical equipment and related services. The current stock price for AHCO is $5.75.
Dimensional Fund Advisors LP reduced its stake in AdaptHealth Corp (AHCO) by selling 1,275,223 shares at $5.64 on September 30, 2026. Despite the reduction, AHCO still accounts for 0.01% of the firm's portfolio, and the stock is considered 33% undervalued according to its GF Value. AdaptHealth Corp, a provider of home medical equipment, faces financial health challenges, including low growth and momentum ranks, despite its apparent undervaluation.
This article analyzes Adapthealth Corp. (NASDAQ: AHCO), highlighting a potential shift from positive near-term sentiment amidst broader weak alignment. It details an exceptional risk-reward setup targeting a 37.5% gain and outlines three AI-generated trading strategies with specific entry, target, and stop-loss zones for different risk profiles. The analysis also includes a multi-timeframe signal breakdown for near-term, mid-term, and long-term outlooks.
The article analyzes Adapthealth Corp. (NASDAQ: AHCO) using AI models, indicating weak sentiment across all time horizons which supports a short bias. It provides specific trading strategies, including long, breakout, and short positions, along with multi-timeframe signal analysis detailing support and resistance levels. The report highlights elevated downside risk and the absence of additional long-term support signals for AHCO.